The Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients With Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data

Muzeyyen Aslaner; S ERTOP; Ayfer Geduk; Merve Gokcen Polat; Ibrahim Halil Acar; B. Guvenc; C. Sunu; Tugba Hacibekiroglu; Ali Zahit Bolaman

The Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients With Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data

Muzeyyen Aslaner, S ERTOP, Ayfer Geduk, Merve Gokcen Polat, Ibrahim Halil Acar, B. Guvenc, C. Sunu, Tugba Hacibekiroglu, Ali Zahit Bolaman

meeting_abstract (Uluslararası, Hakemli) | Yazar(lar): Muzeyyen Aslaner, S ERTOP, Ayfer Geduk, Merve Gokcen Polat, Ibrahim Halil Acar, B. Guvenc, C. Sunu, Tugba Hacibekiroglu, Ali Zahit Bolaman | Yıl: 2023 | Dergi/Kurum: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | İndeks: WOS.SCI | Anahtar Kelimeler: MDS, myelodysplastic sy